Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited has announced that Phyllis Irene Gardner has ceased to be a director of the company as of September 11, 2025. The announcement includes details of Gardner’s holdings, which consist of 600,000 ordinary fully paid shares and 100,000 options at $0.42 expiring on November 23, 2026.
More about Firebrick Pharma Limited
Average Trading Volume: 89,495
Technical Sentiment Signal: Hold
For detailed information about FRE stock, go to TipRanks’ Stock Analysis page.